95299-17-5

Basic information

• Product Name: Methyl2,4-difluorophenylacetate97%
• Synonyms: Methyl2,4-difluorophenylacetate97%;Methyl 2,4-difluorobenzeneacetate;methyl 2-(2,4-difluorophenyl)acetate;Methyl 2,4-difluorophenylacetate
• CAS NO: 95299-17-5
• Molecular Formula: C₉H₈F₂O₂
• Molecular Weight: 186.1554264
• Mol File: 95299-17-5.mol

Chemical Properties

• Boiling Point: 206.0±25.0 °C(Predicted)
• Appearance: /
• Density: 1.235±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Methyl2,4-difluorophenylacetate97%(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl2,4-difluorophenylacetate97%(95299-17-5)
• EPA Substance Registry System: Methyl2,4-difluorophenylacetate97%(95299-17-5)

Safety Data

• Hazardous Substances Data: 95299-17-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2,4-difluorophenylacetate 97% is utilized as a key intermediate for the synthesis of various drugs. Its high purity makes it a preferred choice in the production process, ensuring the quality and efficacy of the final pharmaceutical products.
Used in Organic Compounds Synthesis:
In addition to its pharmaceutical applications, Methyl 2,4-difluorophenylacetate 97% is also employed in the synthesis of other organic compounds. Its unique chemical structure allows it to serve as a valuable building block in the creation of a range of organic molecules.
It is crucial to handle Methyl 2,4-difluorophenylacetate 97% with care and adhere to proper safety protocols during its use to ensure the safety of both individuals and the environment.

Upstream product

• 81228-09-3 2,4-difluorophenylacetic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 

Downstream Products

• 960371-20-4 dimethyl 1-(2,4-difluorophenyl)-4-oxocyclohexane-1,3-dicarboxylate 
• 1240469-67-3 methyl 5-chloro-2-(2,4-difluorophenyl)pentanoate 
• 1374668-02-6 3-(cyclopropylmethyl)-7-{[3-(2,4-difluorophenyl)piperazin-1-yl]methyl}-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine 
• 1266680-51-6 methyl bromo(2,4-difluorophenyl)acetate 
• 1246550-88-8 3-(2,4-difluorophenyl)piperazin-2-one 
• 793657-84-8 2-(2,4-difluorophenyl)piperazine 
• 868049-68-7 1-(2,4-difluorophenyl)-2-methylpropan-2-ol 

Relevant articles and documents

PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

Compounds of Formula (0), Formula (I), and Formula (II) and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF

Provided are a polycyclic pyrazolinone derivative indicated by general formula (1) (in the formula, R1, X1, X2, X3, and Y indicate the definitions provided in the Specification) and a herbicide comprising same as effective component thereof.

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) wherein all radicals are as defined in the claims. The compounds according to the invention are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 ("mGluR2"), which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.

IMIDAZOLYLPYRAZINE DERIVATIVES

To provide a novel low-molecular-weight compound that inhibits the production of amyloid-β (Aβ ). A compound represented by the formula [I]: or a pharmacologically acceptable salt or ester thereof, wherein R1 and R2 are the same or different and each represent a substituent selected from the following Substituent Group a1; m represents an integer of 0 to 3; n represents an integer of 0 to 2; X1 represents a single bond or the like; X2 represents a single bond or the like; Ring A represents a five-membered aromatic heterocyclic group or the like which contains two or more nitrogen atoms and may have 1 to 3 substituents selected from the following Substituent Group b1; and Ring B represents a monocyclic or fused cyclic aromatic ring group such as the formula [2] which may have 1 to 3 substituents selected from the following Substituent Group c1, is effective as a therapeutic agent for a disease such as Alzheimer's disease. Substituent Group a1: a C1-6 alkyl group and the like Substituent Group b1: a C1-6 alkyl group and the like Substituent Group c1: an amino group and the like

Benzamide derivatives and uses related thereto

Benzamide derivatives of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: wherein R1, R2, R3, R4, R5, R6, R7, R8, and n are as defined herein.